Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Botox Rival Gets Emergency Court Order to Stay on U.S. Market

Feb. 16, 2021, 1:53 PM

The makers of a rival to the Botox wrinkle treatment can remain on the market temporarily while a U.S. appeals court considers a longer-term request in a dispute over a trade ruling won by AbbVie’s Allergan that was to go into effect today.

  • Daewoong Pharmaceutical and Evolusfiled the request early Saturday, urging the U.S. Court of Appeals for the Federal Circuit to put on hold an import ban lodged against their treatment, Jeuveau
    • Allergan and its South Korean partner MedyTox Inc. in December won a ruling that Jeuveau is made using MedyTox’s secret process to turn the deadly ...